| Old Articles: <Older 2761-2770 Newer> |
|---|
 |
Bio-IT World
March 2006
Charles Firneno |
Physician Portals Fill the Gap Multifunctional physician/patient portals can provide insight into value and product performance issues. Such insight can be combined with medical claims and pharmacy data as well as with blinded safety data to provide an organic view of product performance.   |
Bio-IT World
March 2006 |
News Blast Merck/Phase Forward... Curbing a Pandemic... Focused Trials... Collaboration... |
Bio-IT World
March 2006
Mark D. Uehling |
Microdoses of Excitement With new federal backing, microdose studies can allow regulators to radically shorten preclinical programs. |
Bio-IT World
March 2006
Kevin Davies |
Clinical Data Launches Landmark Trial Clinical Data has launched a Phase III clinical trial for the depression drug vilazodone and will concurrently develop a diagnostic test. The study could prove to be a landmark event in pharmacogenomic medicine. |
Bio-IT World
March 2006 |
News Blast X Prize... Junk Discovery... Susceptibility... Resistance... |
Bio-IT World
March 2006
Mike May |
The Evolving Grid Computing System at J&J Johnson & Johnson is planning to double the size of its grid computing network and the number of applications that run on it by the end of this year, according to company executives. |
Bio-IT World
March 2006
Salvatore Salamone |
Pfizer Digs Deeper in Mining Trial Data Besides using the information mined from past trials to help design new studies, examine new uses for a drug, or study ways to minimize risks, the data-mining efforts are also being applied to looking at how drugs on the market are being used. |
Bio-IT World
March 2006
Mark D. Uehling |
Oracle Discusses Agenda for Clinical Trials In surprising ways, Fusion is helping to shape Oracle's strategy in the clinical trial space. |
Bio-IT World
March 2006 |
News Blast Franklin Award... New Lims Installed... Databases Licensed... Improved Workflows... |
Bio-IT World
March 2006
Kevin Davies |
Church Inquiry Gets Personal Harvard Medical School geneticist George Church with his plan for the Personal Genome Project is a likely contender for the X Prize that will be awarded to the group or individual that most helps cross the $1,00 genome threshold. |
| <Older 2761-2770 Newer> Return to current articles. |
